Equashield
Developer and manufacturer of closed-system transfer devices (CSTD) and integrated compounding technologies for hazardous drugs. Offers closed-back syringe consumables, closed single-use devices for cell and gene therapy workflows, IV workflow software with EMR integration, and automated compounding systems. Positions products on clinical evidence and provides manufacturing with automated, AI-enabled quality control and global distribution.
Industries
Nr. of Employees
large (251-1000)
Equashield
Patents
Products
Closed-back syringe units (encapsulated plunger, 1 mL–60 mL)
Preassembled sealed syringe units with encapsulated, non-detachable plungers designed to prevent inner-wall exposure, compatible with closed-system connectors.
Membrane-based luer-lock adaptors and connectors
Dual-membrane luer-lock adaptors and swivel variants that enable leak-free, dry connections to standard luer ports and reduce residual drug and disconnection risk.
Closed single-use device family for cell and gene therapy
Pre-sterilized single-use vial adaptors, sampling kits, syringe units and luer/sterile-weld connectors designed to keep cell/gene therapy processes closed from reagent addition through final fill, validated for low volume loss and microbial integrity.
Closed-back syringe units (encapsulated plunger, 1 mL–60 mL)
Preassembled sealed syringe units with encapsulated, non-detachable plungers designed to prevent inner-wall exposure, compatible with closed-system connectors.
Membrane-based luer-lock adaptors and connectors
Dual-membrane luer-lock adaptors and swivel variants that enable leak-free, dry connections to standard luer ports and reduce residual drug and disconnection risk.
Closed single-use device family for cell and gene therapy
Pre-sterilized single-use vial adaptors, sampling kits, syringe units and luer/sterile-weld connectors designed to keep cell/gene therapy processes closed from reagent addition through final fill, validated for low volume loss and microbial integrity.
Services
Order management, drug knowledgebase, barcode-guided kitting, bidirectional EMR/HL7 connectivity, stepwise user guidance, and remote pharmacist verification for traceable order-to-dispense workflows.
Tabletop automated compounder that performs reconstitution, precision fluid transfers, and automated dose verification with image capture to reduce manual handling and exposure.
On-site training, clinical staffing support (pharmacy technicians and nurses), digital knowledge base, and implementation services for product adoption and workflow integration.
Order management, drug knowledgebase, barcode-guided kitting, bidirectional EMR/HL7 connectivity, stepwise user guidance, and remote pharmacist verification for traceable order-to-dispense workflows.
Tabletop automated compounder that performs reconstitution, precision fluid transfers, and automated dose verification with image capture to reduce manual handling and exposure.
On-site training, clinical staffing support (pharmacy technicians and nurses), digital knowledge base, and implementation services for product adoption and workflow integration.
Expertise Areas
- Closed-system transfer devices for hazardous drugs
- Automated hazardous-drug compounding and dose verification
- IV workflow software with EMR/HL7 integration
- Clinical validation and peer-reviewed study coordination
Key Technologies
- Membrane-based dry-connectors
- Encapsulated closed-back syringe design
- Robotic fluid handling and servo-driven compounding
- Image-based verification and OCR
News & Updates
Clinical study reporting elimination of surface contamination with cyclophosphamide and 5-fluorouracil after implementation of a closed-system drug-transfer device in an ambulatory chemotherapy center.
Article describing integration of AI, multi-camera inspection, OCR/UDI reading and predictive maintenance across automated assembly, packaging and warehouse systems.
Press coverage and company statements referencing broad adoption and market leadership claims for its closed-system transfer devices in US pharmacies.
Reported adoption by thousands of hospitals and cited as most-used closed-system transfer device in US pharmacies across multiple years.
Clinical study reporting elimination of surface contamination with cyclophosphamide and 5-fluorouracil after implementation of a closed-system drug-transfer device in an ambulatory chemotherapy center.
Article describing integration of AI, multi-camera inspection, OCR/UDI reading and predictive maintenance across automated assembly, packaging and warehouse systems.
Press coverage and company statements referencing broad adoption and market leadership claims for its closed-system transfer devices in US pharmacies.
Reported adoption by thousands of hospitals and cited as most-used closed-system transfer device in US pharmacies across multiple years.